NYSE:THC
Tenet Healthcare Corporation Stock News
$130.36
-0.600 (-0.458%)
At Close: May 21, 2024
All You Need to Know About Tenet (THC) Rating Upgrade to Strong Buy
01:24pm, Friday, 14'th Jul 2023
Tenet (THC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Healthcare demand outpacing investor expectations, boosting outlook for providers, Mizuho analysts say
08:26am, Tuesday, 11'th Jul 2023
Recent growth in inpatient and outpatient services has been even higher than elevated investor expectations, Mizuho Securities analysts said in a research note Tuesday. Outpatient volume grew 8% in th
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
08:06am, Friday, 16'th Jun 2023
After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but
Tenet Healthcare (THC) Gains 42.1% YTD: More Room to Run?
09:50am, Friday, 26'th May 2023
Tenet Healthcare's (THC) aim to boost USPI's network through continuous buyouts is positioning the company well for growth.
7 Stocks That Wall Street Analysts Are Loving in May
03:28pm, Sunday, 21'st May 2023
Stock screeners can help investors identify stocks to buy based on a variety of criteria. In fact, one helpful predictor of stock price growth can be found with analyst ratings.
Tenet Healthcare: More M&A And Recruitment Efforts Could Imply Undervaluation
02:40pm, Friday, 19'th May 2023
Tenet Healthcare is a diversified healthcare provider. In the last quarter, the company reported one more hospital as compared to that in 2022. As a result, the KPIs improved.
Tenet Healthcare: Shares Undervalued After A Q1 Beat And Raise
10:22am, Tuesday, 16'th May 2023
Health Care Facilities industry companies have performed relatively poorly since late last year amid the broad market rally. With stronger volumes and reimbursement trends in Q1 and in April, Tenet He
Compared to Estimates, Tenet (THC) Q1 Earnings: A Look at Key Metrics
12:11pm, Tuesday, 25'th Apr 2023
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to W
Tenet (THC) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:55am, Friday, 21'st Apr 2023
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading a
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
11:26am, Friday, 14'th Apr 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
4 Stocks in Focus as Hospital Industry Witnesses Improvement
09:57am, Tuesday, 11'th Apr 2023
Easing staffing challenges and technological adoption are aiding the margins of the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Acadia (ACHC) and Tenet Healt
ACHC or THC: Which Hospital Stock is Better-Positioned?
01:42pm, Wednesday, 05'th Apr 2023
Acadia Healthcare (ACHC) and Tenet Healthcare (THC) are poised to grow in the promising hospital space. We try to find out which stock fares better via comparative evaluation.
Tenet Healthcare (THC) Jumps 14.9% YTD: More Growth Ahead?
12:56pm, Thursday, 30'th Mar 2023
Tenet Healthcare's (THC) focus on boosting USPI's network is positioning the company for expedited growth.
David Einhorn's hedge fund crushed the S&P 500 last year. These are the 3 stocks he's counting on for continued outperformance.
08:15am, Saturday, 04'th Mar 2023
David Einhorn's Greenlight Capital returned 36.6% last year thanks to a combination of successful short bets and a portfolio of value-oriented stocks.
Greenlight Capital's David Einhorn is far from bullish, but he sees massive opportunity in a few value names the market has forgotten about.